Laurus Labs' Q2 FY 2025-26 Quarterly Results

Result Summary

• Laurus Labs Ltd reported a 6.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 36.8%.
• Its expenses for the quarter were up by 4.1% QoQ and 17.0% YoY.
• The net profit increased 20.3% QoQ and increased 874.9% YoY.
• The earnings per share (EPS) of Laurus Labs Ltd stood at 3.61 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Laurus Labs Ltd is a prominent player in the pharmaceutical industry, mainly engaged in the production and development of generic APIs, formulations, and biotechnology products. The company operates in various therapeutic areas, including anti-retrovirals, oncology, cardiovascular, anti-diabetics, and others. Laurus Labs is known for its strong focus on innovation and research, which supports its competitive position in the market. As of the data provided, no specific recent developments were mentioned.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), Laurus Labs Ltd reported a total income of ₹1680.43 crores. This represents a sequential increase of 6.4% compared to ₹1580.00 crores in the first quarter of the fiscal year 2026 (Q1FY26). The year-over-year growth is more pronounced, with total income rising by 36.8% from ₹1228.30 crores in the second quarter of the previous fiscal year (Q2FY25). Such figures suggest that the company has been experiencing a robust increase in its revenue generation over both the quarter and the year.

Profitability

The profitability metrics for Laurus Labs Ltd indicate significant growth. The company reported a profit before tax of ₹269.73 crores in Q2FY26, reflecting a 20.3% increase from ₹224.22 crores in Q1FY26. The year-over-year growth is even more substantial, with a 1082.5% rise from ₹22.81 crores in Q2FY25. After accounting for taxes, the profit after tax stood at ₹194.49 crores in Q2FY26, showing a 20.3% increase quarter-over-quarter and an 874.9% increase year-over-year from ₹19.95 crores in Q2FY25. The earnings per share (EPS) also rose to ₹3.61, representing a 19.5% QoQ increase and an 875.7% YoY increase from ₹0.37 in the previous year's same quarter.

Operating Metrics

The total expenses for Laurus Labs Ltd in Q2FY26 were ₹1410.70 crores, marking a 4.1% increase from ₹1355.78 crores in Q1FY26 and a 17.0% increase from ₹1205.49 crores in Q2FY25. Despite the rise in expenses, the company has managed to improve its profitability, as indicated by the substantial growth in profit before and after tax. The tax expense also increased by 20.3% quarter-over-quarter to ₹75.98 crores in Q2FY26, up from ₹63.14 crores in Q1FY26, and by 1392.7% compared to ₹5.09 crores in Q2FY25. These metrics highlight the company's ability to manage its operating costs while achieving significant revenue and profit growth.